Precision Oncology News – Tests to Guide PARP Inhibitors Emerge as New Focus for Public-Private Harmonization Effort
NEW YORK – Hoping to keep up with an increasing number of clinical assays for DNA repair deficiency, nonprofit Friends of Cancer Research is midway through a project aimed at harmonizing existing tests and developing best practices for new entrants. Hillary Stires, FOCR’s director of regulatory and research partnerships, presented early data from the group’s…